Potential Reduction in Alcohol and Sugary Beverage Sales GLP-1 medications are known to reduce cravings for sweets and alcohol for some users, potentially reducing demand in those categories
"We are encouraged by the results of TRIUMPH-4, which highlight the powerful effect of retatrutide, a first-in-class triple agonist, on body weight, pain and physical function
To generate pLJM1-EGFP transfer plasmids, four copies of inhibitory peptide or control peptide with mutated binding motif spaced out by a flexible GST linker and fused to C-terminus of EGFP were obtained (GenScript)
Providers often recommend backup contraception (such as condoms) during the first weeks of GLP-1 therapy initiation, when dosing adjustments are most frequent and gastric changes are most pronounced
This pairs really well with your earlier diabetes tools nice to see these features building on each other.
3.6 Potential Microbiome Changes GLP-1 receptor agonists alter: Gastric motility Transit time Food intake patterns Emerging research suggests that weight loss and altered dietary intake may influence gut microbiota composition. At present, there is insufficient evidence to conclude that GLP-1 drugs independently cause clinically significant microbiome-mediated nutrient depletion